The main molecular pathways that mediate muscle wasting and CC in pancreatic cancer include TGF-β, myostatin and activin, as well as IGF-1/PI3K/Akt and JAK/STAT3 signaling [152,153]. This evidence concerns the gene TGFB1 and pancreatic neoplasm.